APLM vs IMMP

APLM's Piotroski F-Score of 3/9 indicates weak financial health, with significant red flags in profitability, cash flow, and leverage. The company exhibits extreme negative profitability metrics, including a -124.8% operating margin and -380.13% ROE, despite a 380.8% YoY revenue growth. With no Altman Z-Score available and a current ratio of 0.97, liquidity concerns persist. The stock trades at a high Price/Sales of 6.15 and a negative forward P/E of -30.62, suggesting valuation is driven by speculative growth expectations rather than fundamentals. The 52-week price range of $3.66 to $42.12 reflects extreme volatility, and the 5-year return of -98.0% underscores long-term underperformance.

Immutep Limited presents a high-risk profile characterized by a Piotroski F-Score of 4/9, indicating only marginal financial stability. While the company shows strong YoY revenue growth of 91.50% and maintains a healthy current ratio of 2.97, these are overshadowed by a catastrophic operating margin of -763.71% and a total collapse in share price. The stock has lost approximately 78% of its value over the last year and 88.8% in the last month, signaling a severe lack of market confidence and a bearish technical trend of 0/100.